FMP

FMP

Regal Rexnord Corporation (NYSE:RRX) Earnings Overview

  • Regal Rexnord Corporation reported an EPS of $2.51, slightly below the estimated $2.56.
  • The company's revenue for Q3 2025 reached approximately $1.5 billion, surpassing expectations.
  • RRX has a price-to-earnings (P/E) ratio of about 39.88, indicating investor valuation of its earnings.

Regal Rexnord Corporation (NYSE:RRX) is a prominent player in the manufacturing sector, specifically within the Zacks Manufacturing - General Industrial industry. The company is known for its diverse range of products and solutions, catering to various industrial needs. Regal Rexnord competes with other industrial giants, striving to maintain its position through innovation and strategic growth.

On October 29, 2025, RRX reported its earnings, revealing an earnings per share (EPS) of $2.51. This figure, while slightly below the estimated $2.56, shows a small increase from the $2.49 EPS reported in the same quarter last year. The earnings report resulted in a negative surprise of 1.95%, as highlighted by Zacks. Despite this, the company has a history of surpassing consensus EPS estimates in two of the past four quarters.

RRX's revenue for the third quarter of 2025 reached approximately $1.5 billion, surpassing the Zacks Consensus Estimate of $1.49 billion. This marks a 1.3% increase compared to the same period last year. The revenue exceeded expectations by 0.28%, demonstrating the company's ability to generate higher sales than anticipated. Over the last four quarters, RRX has exceeded consensus revenue estimates three times.

The company's financial metrics provide insight into its market valuation. RRX has a price-to-earnings (P/E) ratio of about 39.88, indicating investor willingness to pay for each dollar of earnings. Its price-to-sales ratio is approximately 1.71, reflecting the market value relative to sales. The enterprise value to sales ratio stands at 2.51, while the enterprise value to operating cash flow ratio is around 14.78.

RRX's financial health is further supported by its debt-to-equity ratio of approximately 0.75, suggesting a moderate level of debt compared to equity. The current ratio of about 2.00 indicates the company's capability to cover short-term liabilities with its short-term assets. These metrics are crucial for investors assessing RRX's performance and potential future price movements.